SCHEMBL443741

SCHEMBL443741

[CH2]N=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formaldehyde SCHEMBL359599 0.61
Formaldehyde SCHEMBL15643109 0.61
Formaldehyde SCHEMBL11234651 0.55
SCHEMBL809291 0.55
SCHEMBL821396 0.55
SCHEMBL639659 0.55
Formaldehyde SCHEMBL1460345 0.55
SCHEMBL168279 0.55
SCHEMBL3784745 0.50
Nitrous Acid SCHEMBL2328305 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108490187-A A kind of stabilization, sensitive four collagen type(IV-C)Detection reagent 山东博科生物产业有限公司 2018-09-04 CN claimed
US-5302370-A Form complexes with rhenium and technetium INSTITUT FUR DIAGNOSTIKFORSCHUNG GMBH (DE) 1994-04-12 US claimed
CN-108471748-B Concentrated gibberellin solution formulations 瓦伦特生物科学有限责任公司 2021-04-23 CN disclosed
CN-108490187-A A kind of stabilization, sensitive four collagen type(IV-C)Detection reagent 山东博科生物产业有限公司 2018-09-04 CN disclosed
CN-107106967-A Carbon capture solvents with alcohols and amines and methods of using such solvents 碳清洁解决方案有限公司 2017-08-29 CN disclosed
US-9186347-B1 Hydroxamates as therapeutic agents PHARMACYCLICS LLC (US) 2015-11-17 US disclosed
US-20150320718-A1 NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS PHARMACYCLICS LLC 2015-11-12 US disclosed
CN-102391222-B As the hydroxamic acid ester of therapeutical agent PHARMACYCLICS INC. (US) 2015-10-21 CN disclosed
US-20140301976-A1 NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS PHARMACYCLICS, INC. 2014-10-09 US disclosed
US-8779171-B2 Hydroxamates as therapeutic agents PHARMACYCLICS, INC. (US) 2014-07-15 US disclosed
CN-103459386-A N- (1,2, 5-oxadiazol-3-yl) pyridinecarboxamides and their use as herbicides BAYER IP GMBH 2013-12-18 CN disclosed
US-5571933-A Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) 1996-11-05 US disclosed
US-5567831-A Non-steroidal sulfatase inhibitor compounds and their method of use DUGUESNE UNIVERSITY OF THE HOLY GHOST (US) 1996-10-22 US disclosed
US-5506345-A ANTIHYPOXIC AGENTS AMERSHAM INTERNATIONAL PLC (GB) 1996-04-09 US disclosed
EP-0663900-A1 METAL-OXIME CHELATES FOR USE AS RADIOPHARMACEUTICAL AGENTS AMERSHAM INTERNATIONAL plc (GB) 1995-07-26 EP disclosed
US-5387692-A A bisamine oxime compound containing a 2-nitroimidazole group AMERSHAM INTERNATIONAL PLC (GB) 1995-02-07 US disclosed
WO-1994008949-A2 METAL-OXIME CHELATES FOR USE AS RADIOPHARMACEUTICAL AGENTS AMERSHAM INTERNATIONAL PLC (GB) 1994-04-28 WO disclosed
US-5302370-A Form complexes with rhenium and technetium INSTITUT FUR DIAGNOSTIKFORSCHUNG GMBH (DE) 1994-04-12 US disclosed
US-4894466-A ANTICHOLESTEROL AGENTS MERCK & CO., INC. (US) 1990-01-16 US disclosed
EP-0331240-A2 Intermediates and processes for beta 6-hydroxymethyl HMG-COA MERCK & CO. INC. (US) 1989-09-06 EP disclosed